TLR4 and myasthenia gravis: Prior studies showed that CD14 induced NF-kappa-B activation, cytokine secretion, and immune and inflammatory response by activating TLR4 signaling and TLR signaling cascade [54, 55], suggesting that BZYQ decoction might treat MG by inhibiting CD14/TLR4 signaling pathway.